Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Hepatocellular 6Hepatitis B 5Recurrence 3Lymphoma 3Neoplasms 2Virus Diseases 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Liver Failure, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Glioma 1Fibrosis 1Extensive Stage Lung Small Cell Carcinoma 1Colorectal Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Lamivudine × Clear all
NCT01580202 2017-06-29

Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

Seoul National University Hospital

Phase 3 Completed
180 enrolled

Hepatitis B, Neoplasms

NCT00516945 2013-09-05

A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Hospital Authority, Hong Kong

Phase NA Completed
110 enrolled

Hepatitis B, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡